The Asia Pacific Herpes Simplex Virus Treatment Market would witness market growth of 3.9% CAGR during the forecast period (2022-2028).
Herpes medicine is available in topical treatment forms, the demand for which is continually rising. There are topical cream versions of acyclovir and penciclovir on the market. Pain lasts about four days but is cut short to three and a half days when penciclovir cream is used every two hours. While topical formulations are well-liked, they are not meant to treat herpes simplex. In order to hasten the healing of sores, they are typically administered to alleviate discomfort and agony. Also, topical formulations are user-friendly, making them practical and highly appreciated by diverse consumers.
In addition to increasing the risk of HIV infection and transmission, HSV can cause serious side effects, including keratitis and encephalitis in those suffering from chronic or long-term conditions. This is one of the key factors causing the rise in demand for HSV therapy, especially in light of the rising prevalence of chronic conditions. In addition, when a baby is infected with HSV during delivery in the genital tract, a dangerous illness called neonatal herpes can develop. Therefore, the market benefits from the increased birth rates because neonatal herpes can result in long-term cognitive impairment or infant mortality.
Development is anticipated to be supported by the increased herpes prevalence in developing nations like China and India. Because there are so many regional businesses, the market is fragmented, contributing to the greater adoption rate of generics for the treatment of herpes. Also, the demand is rising due to increased attempts to create a vaccine as a precautionary step to reduce the spread of infection. Therefore, due to advancements in industry infrastructure, an increase in disposable income, and a well-established establishment of domestic companies in the region, Asia-Pacific presents lucrative opportunities for key participants operating in the herpes simplex virus treatment market.
The China market dominated the Asia Pacific Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $164.8 Million by 2028. The Japan market is estimated to grow a CAGR of 3.2% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 4.6% during (2022 - 2028).
Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Herpes Simplex Virus Treatment Market is Projected to reach USD 2.1 Billion by 2028, at a CAGR of 3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Valacyclovir
- Acyclovir
- Famciclovir
By Type
- Herpes simplex virus-1 Infection
- Herpes simplex virus-2 Infection
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Pfizer, Inc.
- Amneal Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Fresenius SE & Co. KGaA
- Novartis AG
- Viatris, Inc.
- Emcure Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Herpes Simplex Virus Treatment Market, by Drug Type
1.4.2 Asia Pacific Herpes Simplex Virus Treatment Market, by Type
1.4.3 Asia Pacific Herpes Simplex Virus Treatment Market, by Distribution Channel
1.4.4 Asia Pacific Herpes Simplex Virus Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type
3.1 Asia Pacific Valacyclovir Market by Country
3.2 Asia Pacific Acyclovir Market by Country
3.3 Asia Pacific Famciclovir Market by Country
Chapter 4. Asia Pacific Herpes Simplex Virus Treatment Market by Type
4.1 Asia Pacific Herpes simplex virus-1 Infection Market by Country
4.2 Asia Pacific Herpes simplex virus-2 Infection Market by Country
Chapter 5. Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel
5.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
5.2 Asia Pacific Hospital Pharmacies Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country
Chapter 6. Asia Pacific Herpes Simplex Virus Treatment Market by Country
6.1 China Herpes Simplex Virus Treatment Market
6.1.1 China Herpes Simplex Virus Treatment Market by Drug Type
6.1.2 China Herpes Simplex Virus Treatment Market by Type
6.1.3 China Herpes Simplex Virus Treatment Market by Distribution Channel
6.2 Japan Herpes Simplex Virus Treatment Market
6.2.1 Japan Herpes Simplex Virus Treatment Market by Drug Type
6.2.2 Japan Herpes Simplex Virus Treatment Market by Type
6.2.3 Japan Herpes Simplex Virus Treatment Market by Distribution Channel
6.3 India Herpes Simplex Virus Treatment Market
6.3.1 India Herpes Simplex Virus Treatment Market by Drug Type
6.3.2 India Herpes Simplex Virus Treatment Market by Type
6.3.3 India Herpes Simplex Virus Treatment Market by Distribution Channel
6.4 South Korea Herpes Simplex Virus Treatment Market
6.4.1 South Korea Herpes Simplex Virus Treatment Market by Drug Type
6.4.2 South Korea Herpes Simplex Virus Treatment Market by Type
6.4.3 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel
6.5 Singapore Herpes Simplex Virus Treatment Market
6.5.1 Singapore Herpes Simplex Virus Treatment Market by Drug Type
6.5.2 Singapore Herpes Simplex Virus Treatment Market by Type
6.5.3 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel
6.6 Malaysia Herpes Simplex Virus Treatment Market
6.6.1 Malaysia Herpes Simplex Virus Treatment Market by Drug Type
6.6.2 Malaysia Herpes Simplex Virus Treatment Market by Type
6.6.3 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel
6.7 Rest of Asia Pacific Herpes Simplex Virus Treatment Market
6.7.1 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type
6.7.2 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type
6.7.3 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Fresenius SE & Co. KGaA
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Viatris, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Research & Development Expense
7.10. Emcure Pharmaceuticals Limited
7.10.1 Company Overview
TABLE 1 Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Valacyclovir Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Valacyclovir Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Acyclovir Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Acyclovir Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Famciclovir Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Famciclovir Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
TABLE 27 China Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 28 China Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 29 China Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 30 China Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 31 China Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 32 China Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 33 China Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 China Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 Japan Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 36 Japan Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 37 Japan Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 38 Japan Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 39 Japan Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 40 Japan Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 41 Japan Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Japan Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 India Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 44 India Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 45 India Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 India Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 India Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 48 India Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 49 India Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 India Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 52 South Korea Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 53 South Korea Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 54 South Korea Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 55 South Korea Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 56 South Korea Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 57 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Singapore Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 60 Singapore Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 61 Singapore Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 62 Singapore Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 63 Singapore Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 64 Singapore Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 65 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Malaysia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 68 Malaysia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 69 Malaysia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 70 Malaysia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 71 Malaysia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 72 Malaysia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 73 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Rest of Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 76 Rest of Asia Pacific Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 77 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 78 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 Key Information – Amneal Pharmaceuticals, INc.
TABLE 86 Key Information – GlaxoSmithKline PLC
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key Information – Glenmark Pharmaceuticals Limited
TABLE 89 key information – Fresenius SE & Co. KGaA
TABLE 90 Key Information – Novartis AG
TABLE 91 key information – Viatris, Inc.
TABLE 92 Key Information – Emcure Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories